Trial Profile
Tolerability, pharmacodynamics and pharmacokinetics of R 1663 administered as multiple ascending doses in male volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Jul 2012
Price :
$35
*
At a glance
- Drugs R 1663 (Primary)
- Indications Venous thromboembolism
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 21 Jul 2012 New trial record
- 03 May 2012 Results published in Thrombosis and Haemostasis.